rs3736729

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001498.4(GCLC):​c.561-110T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.471 in 817,086 control chromosomes in the GnomAD database, including 92,494 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.45 ( 15500 hom., cov: 32)
Exomes 𝑓: 0.48 ( 76994 hom. )

Consequence

GCLC
NM_001498.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.10

Publications

11 publications found
Variant links:
Genes affected
GCLC (HGNC:4311): (glutamate-cysteine ligase catalytic subunit) Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.[provided by RefSeq, Oct 2010]
GCLC-AS1 (HGNC:56649): (GCLC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-53514607-A-C is Benign according to our data. Variant chr6-53514607-A-C is described in ClinVar as [Benign]. Clinvar id is 1274104.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.56 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GCLCNM_001498.4 linkc.561-110T>G intron_variant Intron 4 of 15 ENST00000650454.1 NP_001489.1 P48506Q14TF0
GCLCNM_001197115.2 linkc.447-110T>G intron_variant Intron 3 of 14 NP_001184044.1 P48506Q14TF0E1CEI4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GCLCENST00000650454.1 linkc.561-110T>G intron_variant Intron 4 of 15 NM_001498.4 ENSP00000497574.1 P48506

Frequencies

GnomAD3 genomes
AF:
0.446
AC:
67728
AN:
151952
Hom.:
15485
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.362
Gnomad AMI
AF:
0.443
Gnomad AMR
AF:
0.571
Gnomad ASJ
AF:
0.408
Gnomad EAS
AF:
0.406
Gnomad SAS
AF:
0.527
Gnomad FIN
AF:
0.451
Gnomad MID
AF:
0.455
Gnomad NFE
AF:
0.466
Gnomad OTH
AF:
0.455
GnomAD4 exome
AF:
0.477
AC:
317174
AN:
665014
Hom.:
76994
AF XY:
0.478
AC XY:
171577
AN XY:
358992
show subpopulations
African (AFR)
AF:
0.355
AC:
6340
AN:
17882
American (AMR)
AF:
0.648
AC:
26909
AN:
41512
Ashkenazi Jewish (ASJ)
AF:
0.421
AC:
8899
AN:
21120
East Asian (EAS)
AF:
0.447
AC:
15590
AN:
34912
South Asian (SAS)
AF:
0.519
AC:
35645
AN:
68708
European-Finnish (FIN)
AF:
0.448
AC:
22799
AN:
50910
Middle Eastern (MID)
AF:
0.486
AC:
2042
AN:
4202
European-Non Finnish (NFE)
AF:
0.468
AC:
183149
AN:
391516
Other (OTH)
AF:
0.461
AC:
15801
AN:
34252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
9492
18984
28476
37968
47460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1916
3832
5748
7664
9580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.446
AC:
67768
AN:
152072
Hom.:
15500
Cov.:
32
AF XY:
0.449
AC XY:
33385
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.362
AC:
15018
AN:
41484
American (AMR)
AF:
0.570
AC:
8720
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.408
AC:
1418
AN:
3472
East Asian (EAS)
AF:
0.407
AC:
2102
AN:
5170
South Asian (SAS)
AF:
0.528
AC:
2544
AN:
4820
European-Finnish (FIN)
AF:
0.451
AC:
4759
AN:
10552
Middle Eastern (MID)
AF:
0.455
AC:
133
AN:
292
European-Non Finnish (NFE)
AF:
0.466
AC:
31698
AN:
67968
Other (OTH)
AF:
0.460
AC:
972
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1894
3787
5681
7574
9468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.469
Hom.:
21724
Bravo
AF:
0.450
Asia WGS
AF:
0.469
AC:
1630
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
2.1
DANN
Benign
0.69
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3736729; hg19: chr6-53379405; COSMIC: COSV57597419; COSMIC: COSV57597419; API